| Product Information |
BR-1425_PI_01.pdf
|
| Registration Number |
BR-1425
|
| Generic Name |
Pneumococcal Polysaccharide Conjugate Vaccine, 15
Valent (Adsorbed)
|
| Brand Name |
Vaxneuvance
|
| Dosage Strength |
Formulation: Each dose (0.5 mL) contains: Streptococcus pneumoniae polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 197, 22F, 23F, 33F- 2 ug Streptococcus pneumoniae polysaccharide serotype 6B-4 ug CRM197 -30ug
|
| Dosage Form |
Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Vaccines
|
| Packaging |
Each box contains: 0.5 mL in 1.5 mL Type I pre-filled
glass syringe with bromobutyl plunger stopper and green
polypropylene plunger rod + Two separate needles
|
| Manufacturer |
MSD International GmbH T/A MSD Ireland (Carlow)
|
| Country of Origin |
Ireland
|
| Trader |
N/A
|
| Importer |
Merck Sharp & Dohme (I.A.) LLC
|
| Distributor |
Merck Sharp & Dohme (I.A.) LLC
|
| Application Type |
Monitored Release (Re-application) [Correction]
|
| Issuance Date |
08 February 2023
|
| Expiry Date |
17 October 2027
|